Wegovy is a brand of medicine containing semaglutide. Three questions should remain separate: its approved use, the particular formulation and your own medical assessment. This overview refers to EU information checked on 16 October 2026. Availability and healthcare funding need their own country-specific checks.
What Wegovy is approved for
For adults, EU authorisation covers weight management alongside a reduced-calorie diet and increased physical activity. The initial BMI criteria are at least 30, or at least 27 with a weight-related health condition. These describe the authorised population; they do not automatically result in a prescription.
The injectable form also has an indication for adolescents from age twelve with specific requirements, including obesity and body weight above 60 kilograms. Tablets are intended only for adults. Adult information must therefore not be passed on as instructions for children or teenagers.
Why pens and tablets need separate attention
Both forms contain semaglutide but have different instructions. A tablet is not simply an injection without a needle. Other medicines, meal timing and daily routine can matter when considering practical fit. Ask which requirements apply to the exact product you have been prescribed.
Check publication dates when reading online. Older articles may describe Wegovy only as an injection. The current EMA overview includes both forms. This does not establish that a particular pharmacy or country can supply every presentation immediately.
Setting realistic expectations
Semaglutide influences hunger and fullness, among other processes, and can support weight loss. Trial results describe averages across groups. They are neither your personal timetable nor evidence that you must reach a particular number on the scales.
Discuss the health changes that matter alongside weight. You may want daily movement to feel easier, or help maintaining adequate nutrition with a smaller appetite. A short record of wellbeing, meals and questions can make follow-up more useful than comparing yourself with advertising photographs.
Safety questions to raise beforehand
Tell your clinician about digestive symptoms, kidney problems, eye conditions, pregnancy plans and every other medicine you take. Current product information distinguishes between different circumstances and formulations. The purpose is to understand your risk, not mechanically tick boxes on an internet checklist.
Wegovy must not be used during pregnancy or breastfeeding. A team planning general anaesthesia or deep sedation needs to know that you use it. Agree how these situations should be managed with the relevant professionals instead of designing your own changes.
Handling symptoms and practical uncertainties
Nausea, vomiting, diarrhoea and constipation are recognised adverse effects. Report difficulties early, especially when eating or drinking becomes hard. Persistent severe abdominal pain, breathing difficulties or a sudden deterioration in vision require prompt medical assessment, not a discussion in website comments.
Before starting, establish who to contact, how follow-up will work and what the ongoing total cost may be. Storage, administration and missed-treatment questions should be checked against the current leaflet for your exact formulation. Self-directed changes, pen-click calculations and switching plans are not safe shortcuts.
Common questions
Is Wegovy the same as Ozempic?
Both contain semaglutide, but they are different products with different approved uses. Ozempic is an EU-authorised treatment for type 2 diabetes. Do not substitute one for the other yourself.
Can I change from the pen to a tablet?
A possible change requires a clinical decision. Previous treatment, other medicines and the requirements of each form need consideration. You cannot convert a milligram amount yourself to plan a switch.
Sources & further reading
- EMA: Wegovy – EPAR und Produktinformation
- OASIS 4: Oral semaglutide in adults with overweight or obesity, 2025
- EMA: NAION and semaglutide, 6 June 2025
Sources checked:
Questions and experiences
Share a question or a useful experience about this topic. Every contribution is checked before publication. Comments may be written in different languages.
Loading reader contributions…
Opening the form sets a necessary session cookie. No email address is required. Publication is subject to moderation and is not guaranteed. For deletion requests: Contact